Clinical Trials Arena - News and Views Updated Daily

Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

Avelas doses first patient in Period 2 of AVB-620 study

Avelas Biosciences has dosed the first patient in the Period 2 of a Phase ll...
Read More...

Avelas doses first patient in Period 2 of AVB-620 study

Supporting mental health in a business environment

Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report